T1	Participants 315 343	Subjects were 54 outpatients
T2	Participants 454 487	Subjects treated with fixed doses
T3	Participants 734 816	All treatment groups demonstrated dramatic and persistent decreases in cocaine use
T4	Participants 910 964	trend for more dropouts by subjects taking desipramine
T5	Participants 1161 1243	subjects treated with desipramine to maintain longer periods of cocaine abstinence
T6	Participants 1245 1325	Mean plasma concentration of desipramine in a subsample of our subjects was less
